IntriCon Co. (NASDAQ:IIN) – Equities research analysts at Dougherty & Co issued their Q4 2018 EPS estimates for IntriCon in a research note issued to investors on Tuesday, November 6th. Dougherty & Co analyst R. Ryan forecasts that the technology company will post earnings per share of $0.18 for the quarter. Dougherty & Co has a “Neutral” rating and a $12.00 price objective on the stock.
Other equities research analysts have also recently issued research reports about the stock. TheStreet raised shares of IntriCon from a “c+” rating to a “b” rating in a research note on Friday, August 31st. B. Riley raised their price objective on shares of IntriCon from $62.00 to $73.00 and gave the stock a “buy” rating in a research note on Wednesday, August 22nd. Stifel Nicolaus reaffirmed a “buy” rating and set a $65.00 price objective (up previously from $50.00) on shares of IntriCon in a research note on Thursday, July 26th. Finally, Zacks Investment Research raised shares of IntriCon from a “hold” rating to a “buy” rating and set a $50.00 price objective on the stock in a research note on Wednesday, October 24th. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. IntriCon has a consensus rating of “Buy” and an average price target of $51.25.
IntriCon (NASDAQ:IIN) last issued its quarterly earnings data on Monday, November 5th. The technology company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02. The business had revenue of $30.13 million for the quarter, compared to analysts’ expectations of $30.23 million. IntriCon had a net margin of 4.82% and a return on equity of 22.73%.
In other news, Director Philip Irving Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, August 31st. The shares were sold at an average price of $74.18, for a total transaction of $741,800.00. Following the sale, the director now owns 6,667 shares of the company’s stock, valued at approximately $494,558.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 21.20% of the stock is owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the stock. Columbus Circle Investors acquired a new stake in IntriCon in the 3rd quarter valued at $2,829,000. Integrated Investment Consultants LLC acquired a new stake in IntriCon in the 2nd quarter valued at $308,000. Bank of New York Mellon Corp acquired a new stake in IntriCon in the 2nd quarter valued at $741,000. Rhumbline Advisers acquired a new stake in IntriCon in the 2nd quarter valued at $232,000. Finally, ClariVest Asset Management LLC acquired a new stake in IntriCon in the 2nd quarter valued at $608,000. 39.42% of the stock is currently owned by hedge funds and other institutional investors.
IntriCon Company Profile
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.